[ASND] QoQ Quarter Result on 30-Jun-2022 [#Q2]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
11-May-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- 35.20%
YoY- 39.48%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 33,589 22,896 15,290 6,160 6,828 4,897 1,113 871.33%
PBT -109,617 -202,069 -169,122 -81,366 -125,257 -106,176 -80,343 23.03%
Tax 1,297 5,349 -167 -47 241 -114 5 3981.16%
NP -110,914 -207,418 -168,955 -81,319 -125,498 -106,062 -80,348 24.00%
Tax Rate - - - - - - - -
Total Cost 144,503 230,314 184,245 87,479 132,326 110,959 81,461 46.58%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin -330.21 -905.91 -1,105.00 -1,320.11 -1,837.99 -2,165.86 -7,219.05 -87.23%
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS -1.98 -3.70 -3.03 -1.46 -2.21 -1.97 -1.47 21.98%
EPS Diluted -1.98 -3.70 -3.03 -1.46 -2.21 -1.97 -1.47 21.98%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.